cgp 54626 has been researched along with tert-butylbicyclophosphorothionate in 1 studies
Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (tert-butylbicyclophosphorothionate) | Trials (tert-butylbicyclophosphorothionate) | Recent Studies (post-2010) (tert-butylbicyclophosphorothionate) |
---|---|---|---|---|---|
57 | 0 | 16 | 465 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buzzi, A; Cortez, M; Frantseva, M; Gibson, KM; Liu, C; Shen, L; Snead, OC; Velazquez, JP; Wu, Y | 1 |
1 other study(ies) available for cgp 54626 and tert-butylbicyclophosphorothionate
Article | Year |
---|---|
Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Convulsants; Humans; In Vitro Techniques; Mice; Mice, Knockout; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Protein Subunits; Radioligand Assay; Receptors, GABA-A; Status Epilepticus; Succinate-Semialdehyde Dehydrogenase; Sulfur Radioisotopes | 2006 |